Literature DB >> 17354800

Asymmetry of SPECT perfusion image patterns as a diagnostic feature for Alzheimer's disease.

Vassili A Kovalev1, Lennart Thurfjell, Roger Lundqvist, Marco Pagani.   

Abstract

In this paper we propose a new diagnostic feature for Alzheimer's Disease (AD) which is based on assessment of the degree of inter-hemispheric asymmetry using Single Photon Emission Computed Tomography (SPECT). The asymmetry measure used represents differences in 3D perfusion image patterns in the cerebral hemispheres. We start from the simplest descriptors of brain perfusion such as the mean intensity within pairs of brain lobes, gradually increasing the resolution up to five-dimensional co-occurrence matrices. Evaluation of the method was performed using SPECT scans of 79 subjects including 42 patients with clinical diagnosis of AD and 37 controls. It was found that combination of intensity and gradient features in co-occurrence matrices captures significant differences in asymmetry values between AD and normal controls (p < 0.00003 for all cerebral lobes). Our results suggest that the asymmetry feature is useful for discriminating AD patients from normal controls as detected by SPECT.

Entities:  

Mesh:

Year:  2006        PMID: 17354800     DOI: 10.1007/11866763_52

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  3 in total

1.  The lateralized smell test for detecting Alzheimer's disease: failure to replicate.

Authors:  Richard L Doty; Edgardo A Bayona; Daniel S Leon-Ariza; Juan Cuadros; Inna Chung; Britney Vazquez; Fidias E Leon-Sarmiento
Journal:  J Neurol Sci       Date:  2014-03-19       Impact factor: 3.181

2.  Neurofunctional Signature of Hyperfamiliarity for Unknown Faces.

Authors:  Elisa Negro; Federico D'Agata; Paola Caroppo; Mario Coriasco; Federica Ferrio; Alessia Celeghin; Matteo Diano; Elisa Rubino; Beatrice de Gelder; Innocenzo Rainero; Lorenzo Pinessi; Marco Tamietto
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

3.  Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.

Authors:  M Pagani; F De Carli; S Morbelli; J Öberg; A Chincarini; G B Frisoni; S Galluzzi; R Perneczky; A Drzezga; B N M van Berckel; R Ossenkoppele; M Didic; E Guedj; A Brugnolo; A Picco; D Arnaldi; M Ferrara; A Buschiazzo; G Sambuceti; F Nobili
Journal:  Neuroimage Clin       Date:  2014-11-18       Impact factor: 4.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.